The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
Open accessAbstract
Tumor-associated macrophages (TAMs) represent an important cellular subset within the glioblastoma (WHO grade IV) microenvironment and are a potential therapeutic target. TAMs display a continuum of different polarization states between antitumorigenic M1 and protumorigenic M2 phenotypes, with a lower M1/M2 ratio correlating with worse prognosis. Here, we investigated the effect of macrophage polarization on anti-CD47 antibody-mediated phagocytosis of human glioblastoma cells in vitro, as well as the effect of anti-CD47 on the distribution of M1 versus M2 macrophages within human glioblastoma cells grown in mouse xenografts. Bone marrow-derived mouse macrophages and peripheral blood-derived human macrophages were polarized in vitro toward M1 or M2 phenotypes and verified by flow cytometry. Primary human glioblastoma cell lines were offered as targets to mouse and human M1 or M2 polarized macrophages in vitro. The addition of an anti-CD47 monoclonal antibody led to enhanced tumor-cell phagocytosis by mouse and human M1 and M2 macrophages. In both cases, the anti-CD47-induced phagocytosis by M1 was more prominent than that for M2. Dissected tumors from human glioblastoma xenografted within NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice and treated with anti-CD47 showed a significant increase of M1 macrophages within the tumor. These data show that anti-CD47 treatment leads to enhanced tumor cell phagocytosis by both M1 and M2 macrophage subtypes with a higher phagocytosis rate by M1 macrophages. Furthermore, these data demonstrate that anti-CD47 treatment alone can shift the phenotype of macrophages toward the M1 subtype in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Direct isolation of human central nervous system stem cells
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., Gage, F. H., & Weissman, I. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14720 · Cited by 1,849
Self-citationMajeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Self-citationWillingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Self-citationCD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
Self-citationBruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100
Integrin-associated protein (CD47) and its ligands
Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 878
Glioblastoma multiforme: Pathogenesis and treatment
Alifieris, C., & Trafalis, D. T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.005 · Cited by 820
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776
Self-citationKioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 773
The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
Chao, M. P., Weissman, I. L., & Majeti, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.010 · Cited by 649
Self-citationZhang, M., He, Y., Sun, X., Li, Q., Wang, W., Zhao, A., & Di, W. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-19 · Cited by 528
Self-citationJaguin, M., Houlbert, N., Fardel, O., & Lecureur, V. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.01.010 · Cited by 518
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Takenaka, K., Prasolava, T. K., Wang, J. C. Y., Mortin-Toth, S. M., Khalouei, S., Gan, O. I., Dick, J. E., & Danska, J. S. (2007) · Nature Immunology · doi:10.1038/ni1527 · Cited by 509
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Weiskopf, K., Ring, A. M., Ho, C. C. M., Volkmer, J.-P., Levin, A. M., Volkmer, A. K., Özkan, E., Fernhoff, N. B., van de Rijn, M., Weissman, I. L., et al. (2013) · Science · doi:10.1126/science.1238856 · Cited by 495
Self-citationBIGNER, D. D., BIGNER, S. H., PONTÉN, J., WESTERMARK, B., MAHALEY, M. S., RUOSLAHTI, E., HERSCHMAN, H., ENG, L. F., & WIKSTRAND, C. J. (1981) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198105000-00001 · Cited by 480
Comparison of polarization properties of human adult microglia and blood‐derived macrophages
Durafourt, B. A., Moore, C. S., Zammit, D. A., Johnson, T. A., Zaguia, F., Guiot, M., Bar‐Or, A., & Antel, J. P. (2012) · Glia · doi:10.1002/glia.22298 · Cited by 477
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
Liu, J., Wang, L., Zhao, F., Tseng, S., Narayanan, C., Shura, L., Willingham, S., Howard, M., Prohaska, S., Volkmer, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137345 · Cited by 475
Self-citationLiu, C.-Y., Xu, J.-Y., Shi, X.-Y., Huang, W., Ruan, T.-Y., Xie, P., & Ding, J.-L. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.69 · Cited by 465
CD163: a regulated hemoglobin scavenger receptor with a role in the anti‐inflammatory response
Moestrup, S., & Møller, H. (2004) · Annals of Medicine · doi:10.1080/07853890410033171 · Cited by 442
Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 437
CD47 functions as a molecular switch for erythrocyte phagocytosis
Burger, P., Hilarius-Stokman, P., de Korte, D., van den Berg, T. K., & van Bruggen, R. (2012) · Blood · doi:10.1182/blood-2011-10-386805 · Cited by 338
Alternative versus Classical Activation of Macrophages
Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C.-D., Dippel, E., Kodelja, V., et al. (1999) · Pathobiology · doi:10.1159/000028096 · Cited by 324
Flow Cytometric Characterization of Tumor-associated Macrophages in Experimental Gliomas
Badie, B., & Schartner, J. M. (2000) · Neurosurgery · doi:10.1097/00006123-200004000-00035 · Cited by 278
Zhao, X. W., van Beek, E. M., Schornagel, K., Van der Maaden, H., Van Houdt, M., Otten, M. A., Finetti, P., Van Egmond, M., Matozaki, T., Kraal, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106550108 · Cited by 276
Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk
Feng, M., Chen, J. Y., Weissman-Tsukamoto, R., Volkmer, J.-P., Ho, P. Y., McKenna, K. M., Cheshier, S., Zhang, M., Guo, N., Gip, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424907112 · Cited by 253
Self-citationProgrammed cell removal: a new obstacle in the road to developing cancer
Chao, M. P., Majeti, R., & Weissman, I. L. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3171 · Cited by 245
Self-citationTherapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Sarkar, S., Döring, A., Zemp, F. J., Silva, C., Lun, X., Wang, X., Kelly, J., Hader, W., Hamilton, M., Mercier, P., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3597 · Cited by 207
Hassanzadeh Ghassabeh, G., De Baetselier, P., Brys, L., Noël, W., Van Ginderachter, J. A., Meerschaut, S., Beschin, A., Brombacher, F., & Raes, G. (2006) · Blood · doi:10.1182/blood-2005-04-1485 · Cited by 177
Carvalho da Fonseca, A. C., & Badie, B. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/264124 · Cited by 174
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
Poli, A., Wang, J., Domingues, O., Planagumà, J., Yan, T., Rygh, C. B., Skaftnesmo, K. O., Thorsen, F., McCormack, E., Hentges, F., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1291 · Cited by 119
Cranial Irradiation Alters the Brain’s Microenvironment and Permits CCR2+ Macrophage Infiltration
Morganti, J. M., Jopson, T. D., Liu, S., Gupta, N. M., & Rosi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093650 · Cited by 111
Kim, M. J., Lee, J.-C., Lee, J., Kim, S., Lee, S. G., Park, S., Sung, M. W., & Heo, D. S. (2008) · Tumor Biology · doi:10.1159/000132568 · Cited by 101
Hedbrant, A., Erlandsson, A., Delbro, D. S., & Wijkander, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2203 · Cited by 97
Lee, J., Lee, G. T., Woo, S. H., Ha, Y., Kwon, S. J., Kim, W., & Kim, I. Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4563 · Cited by 93
Expression of Tumor-Associated Macrophage in Progression of Human Glioma
Ding, P., Wang, W., Wang, J., Yang, Z., & Xue, L. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0105-3 · Cited by 78
SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells
Nuvolone, M., Kana, V., Hütter, G., Sakata, D., Mortin-Toth, S. M., Russo, G., Danska, J. S., & Aguzzi, A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131274 · Cited by 70
Macrophages require Skap2 and Sirpα for integrin-stimulated cytoskeletal rearrangement
Alenghat, F. J., Baca, Q. J., Rubin, N. T., Pao, L. I., Matozaki, T., Lowell, C. A., Golan, D. E., Neel, B. G., & Swanson, K. D. (2012) · Journal of Cell Science · doi:10.1242/jcs.111260 · Cited by 58
Zen, K., Guo, Y., Bian, Z., Lv, Z., Zhu, D., Ohnishi, H., Matozaki, T., & Liu, Y. (2013) · Nature Communications · doi:10.1038/ncomms3436 · Cited by 55
Boukhari, A., Alhosin, M., Bronner, C., Sagini, K., Truchot, C., Sick, É., Schini‐Kerth, V. B., André, P., Mély, Y., Mousli, M., et al. (2015) · PubMed · Cited by 54
M2-polarised macrophages in infantile haemangiomas: correlation with promoted angiogenesis
Wang, F., Chen, G., Zhu, J., Zhang, W., Ren, J., Liu, H., Sun, Z., Jia, J., & Zhao, Y. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201286 · Cited by 47
Pan, Y., Tan, Y., Wang, M., Zhang, J., Zhang, B., Yang, C., Ding, Z., Dong, L., & Wang, H. (2013) · Hepatology · doi:10.1002/hep.26391 · Cited by 46
Monocyte-Derived Cells of the Brain and Malignant Gliomas: The Double Face of Janus
Kushchayev, S. V., Kushchayeva, Y. S., Wiener, P. C., Scheck, A. C., Badie, B., & Preul, M. C. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2012.11.059 · Cited by 45
Parney, I. F., Chang, L.-J., Farr-Jones, M. A., Hao, C., Smylie, M., & Petruk, K. C. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9058-0 · Cited by 42
Vaccine therapies for patients with glioblastoma
Sayegh, E. T., Oh, T., Fakurnejad, S., Bloch, O. G., & Parsa, A. T. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1502-6 · Cited by 36
Wong, A. S. L., Mortin-Toth, S. M., Sung, M., Canty, A. J., Gulban, O., Greaves, D. R., & Danska, J. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401984 · Cited by 35
On the mechanism of CD47 targeting in cancer
Zhao, X. W., Matlung, H. L., Kuijpers, T. W., & van den Berg, T. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209265109 · Cited by 35
Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma
Casulo, C., Arcila, M. E., Bohn, O. L., Teruya‐Feldstein, J., Maragulia, J. C., & Moskowitz, C. H. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.03.021 · Cited by 31
Soto‐Pantoja, D. R., Miller, T. W., Frazier, W. A., & Roberts, D. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205441109 · Cited by 25
Santos, M. A., Pignon, J., Blanchard, P., Lefeuvre, D., Lévy, A., Touat, M., Louvel, G., Dhermain, F. G., Soria, J., Deutsch, É., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1802-5 · Cited by 17
Iizuka, A., Komiyama, M., Oshita, C., Kume, A., Ashizawa, T., Mitsuya, K., Hayashi, N., Nakasu, Y., Yamaguchi, K., & Akiyama, Y. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.02.004 · Cited by 7
Cited by
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Xia, Y., Rao, L., Yao, H., Wang, Z., Ning, P., & Chen, X. (2020) · Advanced Materials · doi:10.1002/adma.202002054 · Cited by 949
Phagocytosis checkpoints as new targets for cancer immunotherapy
Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y.-X., & Weissman, I. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0183-z · Cited by 911
Self-citationMechanisms of immunotherapy resistance: lessons from glioblastoma
Jackson, C. M., Choi, J., & Lim, M. (2019) · Nature Immunology · doi:10.1038/s41590-019-0433-y · Cited by 751
Glioma targeted therapy: insight into future of molecular approaches
Yang, K., Wu, Z., Zhang, H., Zhang, N., Wu, W., Wang, Z., Dai, Z., Zhang, X., Zhang, L., Peng, Y., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01513-z · Cited by 704
Metadata
- Authors
- Zhang, M., Hutter, G., Kahn, S. A., Azad, T. D., Gholamin, S., Xu, C. Y., Liu, J., Achrol, A. S., Richard, C., Sommerkamp, P., Schoen, M. K., McCracken, M. N., Majeti, R., Weissman, I., Mitra, S. S., & Cheshier, S. H.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-04-19
- Volume
- 11
- Issue
- 4
- Pages
- e0153550
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2341432578
- Cited by
- 330
- References
- 60
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.